Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Posted by

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi
Post a Comment
Read more
Labels
Posted by

Vividthree Holdings Ltd

For Information Only



Vividthree Holdings Ltd ("Vividthree" or the "Company") is placing out 51.8m shares at $0.25 each. The IPO has closed and will be listed on 25 Sep 2018. The market cap based on the IPO price is $83.50 million

Principal Business

The company is founded in 2006 and currently has a presence in Singapore and Malaysia. It is a virtual reality, visual effects and computer-generated imagery studio focused on content production and post-production. 


As part of its business strategies, vividthree intends to build up its digital IP through development of VR products and other immersive experiences. It also intends to expand overseas and make strategic acquisitions. 

Competitive Strengths


Financial Highlights


The Company has been profitable for the last 3 years where revenue grew from $3.9m to $7.06m and net profit as of FY2018 was $2.17m. The EPS based on the enlarged shares is 0.81 cents.


The pro-forma EPS is 0.86 cents and that translates into a PE ratio of 29x. The NAV per share is around 3.82 cents.


This is basically a human capital business. The margins are high but the ability to win deals and retain talents are equally important. 

What I Like about the Company
  • Increased use of VR technology - The use of visual effects is very common in movies nowadays and vividthree was involved in computer-generated imagery works in "Ah Boys to Men" series. The challenge will be winning the projects and the lineage to MM2 Asia should help
  • Creating IP content - The Company will produce thematic tour shows based on IP rights acquired or licensed from 3rd parties. On that front, vividthree is developing a VR thematic tour show based on the film "Train to Busan", which was very well received. This would be the most "exciting" segment if they are able to execute well
  • Profitable - While the listing valuation is high, at least the company is profitable and able to operate on the standalone basis.
Some of my concerns
  • Competitive landscape - The VR business is highly competitive and the ability of vividthree to expand beyond its "ah boys to men" fame will be important for its regional expansion
  • Thematic tour shows not proven yet - The company reminded me somewhat of Cityneon's expansion into different thematic sets by Avengers and they are doing the same with VR thematic shows, starting with popular movies such as Train to Busan. If it is successful, it will create a name and market for itself 
  • Transfer pricing - The Company will have business with its parent, MM2 Asia. While the relationships helps open doors, there could be potential transfer pricing considerations as MM2 Asia is involved in movie productions as well. The ability to deal at arm's length with MM2 Asia related projects will be important. 
  • MM2-related listings - MM2 Asia has been very successful in acquiring and then listing its different business units. Unsual Productions and Vividthree is a series of such spin outs. While i don't want to draw parallels with how Ezra spun out its different units previously, I genuinely hope this "spin out trends" doesn't continue as MM2 Asia is arbitraging the difference between the valuation at which they acquired the companies and subsequently listing these entities 
Mr IPO's view

From MM2 Asia to Unusual Productions, Melvin Ang has a group of "strong" supporters behind him. I envisage the support for vividthree will be similar. Even though the valuation of vividthree is high at 29x, i believe the mm2 "fans" will continue to support him.  

As such, despite the weak sentiment, my "anyhow" guess is that it will be 2 chili rating opening. Good luck to those who had received the shares. 

Email Post
Labels:

Comments

Post a Comment